73 related articles for article (PubMed ID: 21618422)
1. Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: a report from the Children's Oncology Group.
Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
Pediatr Blood Cancer; 2012 Apr; 58(4):519-24. PubMed ID: 21618422
[TBL] [Abstract][Full Text] [Related]
2. Incidence, risk factors, and outcome of asymptomatic central nervous system involvement in adult patients with acute myeloid leukemia.
Virijevic M; Kraguljac-Kurtovic N; Mitrovic M; Jakovic L; Bukumuric Z; Pantic N; Sabljic N; Pravdic Z; Cvetkovic M; Knezevic V; Dragovic-Ivancevic T; Djunić I; Rajic J; Milosevic V; Todorovic-Balint M; Vidovic A; Suvajdzic-Vukovic N
Hematol Oncol; 2024 Mar; 42(2):e3253. PubMed ID: 38536200
[TBL] [Abstract][Full Text] [Related]
3. Systematic review and meta-analysis evaluating clinical outcomes in adult acute myeloid leukemia patients with central nervous system involvement.
Goulart H; Sastow D; Moshier E; Martin L; Mascarenhas J; Tremblay D
Leuk Res; 2024 Feb; 137():107452. PubMed ID: 38335816
[TBL] [Abstract][Full Text] [Related]
4. Exclusion of Acute Myeloid Leukemia Patients with Central Nervous System Involvement from Clinical Trials: An Analysis of the National Institutes of Health Clinical Trials Registry from 2012 to 2022.
Sastow D; Van Hyfte G; Feld J; Kremyanskaya M; Mascarenhas J; Tremblay D
Acta Haematol; 2024; 147(3):292-299. PubMed ID: 37751713
[TBL] [Abstract][Full Text] [Related]
5. The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy.
Buckley SA; Othus M; Estey EH; Walter RB
Blood Cancer J; 2015 Jan; 5(1):e276. PubMed ID: 25635529
[No Abstract] [Full Text] [Related]
6. Pediatric Myeloid Sarcoma of the Testes Treated With Surgery and Adjuvant Radiation Therapy.
Miller S; Jeberaeel J; Saad A; Abd Almohsen N; Vaishampayan N
Cureus; 2024 Mar; 16(3):e57029. PubMed ID: 38681318
[TBL] [Abstract][Full Text] [Related]
7. Myeloid sarcoma with RAM phenotype in an adult male presenting with CNS relapse; no longer a pediatric disease.
Panda D; Tejwani N; Pandey P; Mehta A; Rainchwar S; Panda T; Halder R; Palatty RJ; Agrawal N; Bhurani D
Ann Hematol; 2024 Apr; ():. PubMed ID: 38676766
[No Abstract] [Full Text] [Related]
8. Air Pollutant Impact on Disease Characteristics and Outcomes in Patients with Acute Myeloid Leukemia.
Palmer AS; Rauscher GH; Abraham IE; Burkart M; Dave A; Raptis NI; Aleem A; Gannamani V; Erra A; Monick S; Galvez C; Shah SAM; Rahmani Youshanlouei H; Larson ML; Zia M; Tsai SB; Altman JK; Stock W; Khan I; Patel AA
Blood Adv; 2024 May; ():. PubMed ID: 38810264
[No Abstract] [Full Text] [Related]
9. Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia.
Rozovski U; Ohanian M; Ravandi F; Garcia-Manero G; Faderl S; Pierce S; Cortes J; Estrov Z
Leuk Lymphoma; 2015 May; 56(5):1392-7. PubMed ID: 25110819
[TBL] [Abstract][Full Text] [Related]
10. Very late isolated CNS relapse of acute myeloid leukemia.
Molina B; Lassaletta A; Gonzalez-Vicent M; Andión M; Diaz MA; Madero L
J Pediatr Hematol Oncol; 2013 Mar; 35(2):e57-9. PubMed ID: 23412589
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system involvement by myeloid sarcoma: a report of 12 cases and review of the literature.
Olar A; Lapadat R; Davidson CJ; Stein TD; Dahiya S; Perry A; Gheorghe G
Clin Neuropathol; 2016; 35(5):314-25. PubMed ID: 27125868
[TBL] [Abstract][Full Text] [Related]
12. Intracranial CNS Manifestations of Myeloid Sarcoma in Patients with Acute Myeloid Leukemia: Review of the Literature and Three Case Reports from the Author's Institution.
Cervantes GM; Cayci Z
J Clin Med; 2015 May; 4(5):1102-12. PubMed ID: 26239467
[TBL] [Abstract][Full Text] [Related]
13. Pediatric acute myeloid leukemia with breast chloromas.
Gallardo MS; Joyrich R; Taub JW
EJHaem; 2023 May; 4(2):488-490. PubMed ID: 37206254
[No Abstract] [Full Text] [Related]
14. Pediatric Myeloid Sarcoma, More than Just a Chloroma: A Review of Clinical Presentations, Significance, and Biology.
Zorn KE; Cunningham AM; Meyer AE; Carlson KS; Rao S
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900239
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics, pathology features and outcomes of pediatric myeloid sarcoma: A retrospective case series.
Ye F; Zhang H; Zhang W; Dong J; Deng W; Yang L
Front Pediatr; 2022; 10():927894. PubMed ID: 36545668
[TBL] [Abstract][Full Text] [Related]
16. Successful Treatment of Pediatric Acute Myeloid Leukemia Presenting with Hyperbilirubinemia Secondary to Myeloid Sarcoma: A Case Report.
Shash HA; Khairy AM
Children (Basel); 2022 Nov; 9(11):. PubMed ID: 36360428
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Treatment Outcomes of Myeloid Sarcoma in Children: The Experience of the Polish Pediatric Leukemia and Lymphoma Study Group.
Samborska M; Barańska M; Wachowiak J; Skalska-Sadowska J; Thambyrajah S; Czogała M; Balwierz W; Kołtan S; Peszyńska-Żelazny K; Wysocki M; Ociepa T; Urasiński T; Wróbel G; Węcławek-Tompol J; Ukielska B; Chybicka A; Kitszel A; Krawczuk-Rybak M; Szmydki-Baran A; Malinowska I; Matysiak M; Mizia-Malarz A; Tomaszewska R; Szczepański T; Chodała-Grzywacz A; Karolczyk G; Maciejka-Kembłowska L; Irga-Jaworska N; Badowska W; Dopierała M; Kurzawa P; Derwich K
Front Oncol; 2022; 12():935373. PubMed ID: 35875115
[TBL] [Abstract][Full Text] [Related]
18. Epidural Spinal Cord Compression as the Presenting Manifestation of Acute Myeloid Leukemia: A Case Report and Literature Review.
Fujikawa T; Kishimoto K; Inoue S; Nishimura A; Tojo R; Uemura S; Nakamura S; Saito A; Kozaki A; Ishida T; Mori T; Higashino M; Koyama J; Kawamura A; Hasegawa D; Kosaka Y
Intern Med; 2023 Feb; 62(3):453-457. PubMed ID: 35793962
[TBL] [Abstract][Full Text] [Related]
19. Acute Myeloid Leukemia Transformation from Myelofibrosis Upon Remission of an Orbital Myeloid Sarcoma - A Case Report.
Chen N; Lin CS; Hsu YH; Huang WH; Huang CT; Lee YC
Int Med Case Rep J; 2021; 14():443-448. PubMed ID: 34234577
[TBL] [Abstract][Full Text] [Related]
20. Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia.
Kaeding AJ; Barwe SP; Gopalakrishnapillai A; Ries RE; Alonzo TA; Gerbing RB; Correnti C; Loken MR; Broderson LE; Pardo L; Le QH; Tang T; Leonti AR; Smith JL; Chou CK; Xu M; Triche T; Kornblau SM; Kolb EA; Tarlock K; Meshinchi S
Blood Adv; 2021 May; 5(9):2350-2361. PubMed ID: 33938941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
